Kristina Søborg Pedersen

Kristina Søborg Pedersen is a Radiochemist at the Department of Health Technology, Technical University of Denmark (DTU), specializing in therapeutic radionuclide development for cancer treatment. Her work focuses on cyclotron-based production and purification of novel isotopes including copper-67 and lanthanum-135 for targeted radionuclide therapy.

Education

• PhD in Health Technology, Technical University of Denmark (2016-2020)

Research Interests

Dr. Pedersen's research centers on radiochemistry and nuclear medicine, with emphasis on optimizing production routes for emerging therapeutic radionuclides. She develops advanced purification techniques using liquid-liquid extraction and resin-based methods, and evaluates biological efficacy through preclinical SPECT/CT imaging. Her work targets Auger electron emitters and theranostic pairs for precision oncology applications.

Publication Trends

Her 2022-2025 publications reveal a concentrated effort in establishing biomedical cyclotron production for underutilized therapeutic radionuclides. Key innovations include zinc-targeted copper-67 synthesis and barium-carbonate-based lanthanum-135 generation, coupled with novel purification protocols. These advances address critical supply chain gaps for alpha and Auger-particle therapies, demonstrating translational potential for clinical oncology.

Scientific Awards

No awards documented in available sources.

Grants and Projects

• Completed PhD project (2016-2020): "New approaches to chemical recovery and chelation of underdeveloped radiometals and application of their novel bioconjugates to PET" involving liquid-liquid extraction techniques and positron emission tomography applications

Labs and Teams

Dr. Pedersen operates within the Targeted Radionuclides group (Hevesy Laboratory) under DTU Health Tech's Cell and Drug Technologies section, collaborating on radiochemistry infrastructure and radiopharmaceutical development for the Danish nuclear medicine community.